HUTCHMED (China) (HCM) Change in Working Capital (2020 - 2021)

HUTCHMED (China) (HCM) reported Change in Working Capital of $1.5 million for Q1 2021, up 187.08% year-over-year from $511000.0 in Q1 2020, and up 187.08% quarter-over-quarter from $511000.0 in Q1 2020.

HUTCHMED (China) (HCM) Change in Working Capital (2020 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 2 years of Change in Working Capital data on file, last reported at $1.5 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn -617.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn -
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn -
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -
10 HUTCHMED (China) 1.21 Bn -261.65 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 1.47 Mn
Mar 31, 2021 1.47 Mn
Mar 31, 2020 511,000.00
Mar 31, 2020 511,000.00